Good prognosis for follicular lymphoma with estrogen receptor α-positive follicular dendritic cells.
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
/ metabolism
Dendritic Cells, Follicular
/ metabolism
Estrogen Receptor alpha
/ metabolism
Female
Follow-Up Studies
Humans
Immunohistochemistry
In Situ Hybridization
Lymphoma, Follicular
/ metabolism
Male
Middle Aged
Prognosis
Survival Rate
Tumor Microenvironment
FLIPI
Prognosis
estrogen receptor alpha
follicular dendritic cell
follicular lymphoma
Journal
Hematological oncology
ISSN: 1099-1069
Titre abrégé: Hematol Oncol
Pays: England
ID NLM: 8307268
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
24
11
2019
revised:
21
01
2020
accepted:
09
03
2020
pubmed:
21
3
2020
medline:
1
9
2020
entrez:
21
3
2020
Statut:
ppublish
Résumé
Follicular lymphoma (FL) has a meshwork of follicular dendritic cells (FDCs). We previously demonstrated the presence of estrogen receptor alpha (ERα)
Identifiants
pubmed: 32196124
doi: 10.1002/hon.2730
pmc: PMC7496718
doi:
Substances chimiques
Biomarkers, Tumor
0
ESR1 protein, human
0
Estrogen Receptor alpha
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
293-300Subventions
Organisme : Japan Society for the Promotion of Science
ID : JP17K08736
Organisme : Japan Society for the Promotion of Science
ID : JP19K16577
Informations de copyright
© 2020 The Authors. Hematological Oncology published by John Wiley & Sons Ltd.
Références
Histopathology. 2011 Mar;58(4):586-92
pubmed: 21401698
Br J Haematol. 2016 Oct;175(1):102-14
pubmed: 27341313
Lancet Oncol. 2015 Sep;16(9):1111-1122
pubmed: 26256760
J Clin Oncol. 2015 Aug 10;33(23):2516-22
pubmed: 26124482
Br J Haematol. 2020 Jan;188(2):249-258
pubmed: 31385309
Pathol Int. 2011 Dec;61(12):737-41
pubmed: 22126381
Blood. 2004 Sep 1;104(5):1258-65
pubmed: 15126323
Leuk Lymphoma. 2016 Jul;57(7):1687-96
pubmed: 26700650
Semin Cancer Biol. 2015 Oct;34:3-13
pubmed: 25794825
Ann Hematol. 2018 Feb;97(2):209-227
pubmed: 29032510
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
J Leukoc Biol. 2019 May;105(5):983-998
pubmed: 30645008
J Clin Oncol. 2009 Sep 20;27(27):4555-62
pubmed: 19652063
Haematologica. 2015 Nov;100(11):e458-61
pubmed: 26250574
Hematol Oncol. 2019 Apr;37(2):151-159
pubmed: 30736096
Transl Res. 2015 Sep;166(3):281-91
pubmed: 25953661
Hematol Oncol. 2020 Aug;38(3):293-300
pubmed: 32196124
Br J Haematol. 2009 May;145(4):468-80
pubmed: 19344401
Blood. 2018 Jan 11;131(2):226-235
pubmed: 29122756
Transl Res. 2016 Oct;176:1-17
pubmed: 27187742
Blood. 2017 Jul 20;130(3):258-266
pubmed: 28408460
Pathol Int. 2014 Mar;64(3):95-103
pubmed: 24698419
Exp Cell Res. 2019 Aug 15;381(2):256-264
pubmed: 31112736
Am J Surg Pathol. 2018 Nov;42(11):1466-1471
pubmed: 30307409
Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3:264-72
pubmed: 25597633
Cell Stem Cell. 2014 Dec 4;15(6):791-804
pubmed: 25479752
Am J Pathol. 1999 Sep;155(3):805-14
pubmed: 10487838
J Clin Exp Hematop. 2016;56(1):1-19
pubmed: 27334853